
Pharmaceutical Executive
@PharmExec • 34,700 subscribers
Official Twitter account for Pharmaceutical Executive, a digital and print magazine offering news and opinions, analysis, features and executive profiles.
Videos

Most employer GLP-1 coverage stops at diabetes and weight loss. But the drugs are being studied for cardiovascular, liver, kidney disease, and more. Susan Thomas of @LucyRx on where coverage still falls short: #GLP1 #EmployerBenefits #PharmExec
Pharmaceutical Executive24,508 просмотров • 1 месяц назад
Больше нет контента для загрузки